521 related articles for article (PubMed ID: 25902814)
1. Burden of migraine related to menses: results from the AMPP study.
Pavlović JM; Stewart WF; Bruce CA; Gorman JA; Sun H; Buse DC; Lipton RB
J Headache Pain; 2015 Mar; 16():24. PubMed ID: 25902814
[TBL] [Abstract][Full Text] [Related]
2. Population-Based Characterization of Menstrual Migraine and Proposed Diagnostic Criteria.
Chalmer MA; Kogelman LJA; Ullum H; Sørensen E; Didriksen M; Mikkelsen S; Dinh KM; Brodersen T; Nielsen KR; Bruun MT; Banasik K; Brunak S; Erikstrup C; Pedersen OB; Ostrowski SR; Olesen J; Hansen TF
JAMA Netw Open; 2023 May; 6(5):e2313235. PubMed ID: 37184838
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study.
Grazzi L; Egeo G; Calhoun AH; McClure CK; Liebler E; Barbanti P
J Headache Pain; 2016 Dec; 17(1):91. PubMed ID: 27699586
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
6. A prospective comparison between ICHD-II and probability menstrual migraine diagnostic criteria.
Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
Headache; 2010 Apr; 50(4):539-50. PubMed ID: 20236338
[TBL] [Abstract][Full Text] [Related]
7. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
8. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB
Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
[TBL] [Abstract][Full Text] [Related]
9. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
Headache; 2010 Apr; 50(4):551-62. PubMed ID: 20236337
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
11. Menstrual migraine.
Silberstein SD
J Womens Health Gend Based Med; 1999 Sep; 8(7):919-31. PubMed ID: 10534294
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial.
MacGregor EA; Victor TW; Hu X; Xiang Q; Puenpatom RA; Chen W; Campbell JC
Headache; 2010 Apr; 50(4):528-38. PubMed ID: 20236340
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University.
Dzoljic E; Sipetic S; Vlajinac H; Marinkovic J; Brzakovic B; Pokrajac M; Kostic V
Headache; 2002 Mar; 42(3):185-93. PubMed ID: 11903541
[TBL] [Abstract][Full Text] [Related]
14. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
[TBL] [Abstract][Full Text] [Related]
15. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S
Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684
[TBL] [Abstract][Full Text] [Related]
16. An analysis of migraine triggers in a clinic-based population.
Andress-Rothrock D; King W; Rothrock J
Headache; 2010 Sep; 50(8):1366-70. PubMed ID: 21044280
[TBL] [Abstract][Full Text] [Related]
17. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
18. Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool.
Tepper SJ; Zatochill M; Szeto M; Sheftell F; Tepper DE; Bigal M
Headache; 2008; 48(10):1419-25. PubMed ID: 19076645
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of menstrually related and non-menstrual migraine.
Güven B; Güven H; Çomoğlu S
Acta Neurol Belg; 2017 Sep; 117(3):671-676. PubMed ID: 28560689
[TBL] [Abstract][Full Text] [Related]
20. Symptoms of premenstrual syndrome in female migraineurs with and without menstrual migraine.
Vetvik KG; MacGregor EA; Lundqvist C; Russell MB
J Headache Pain; 2018 Oct; 19(1):97. PubMed ID: 30332985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
